Add-on Acquisition • Life Science

Viatris Acquires Famy Care

On February 2, 2015, Viatris acquired life science company Famy Care from AIF Capital for 750M USD

Acquisition Context
  • This is Viatris’ 5th transaction in the Life Science sector.
  • This is Viatris’ 6th largest (disclosed) transaction.
  • This is Viatris’ 3rd transaction in India.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free


M&A Deal Summary

Date February 2, 2015
Target Famy Care
Sector Life Science
Buyer(s) Viatris
Sellers(s) AIF Capital
Deal Type Add-on Acquisition
Deal Value 750M USD

Target Company

Famy Care

Mumbai, India
Famy Care Ltd is a family owned pharmaceutical manufacturer based in India. The company specializes in the women’s healthcare market, specifically contraceptive formulations and devices.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Viatris

Canonsburg, Pennsylvania, United States

Category Company
Founded 1961
Sector Life Science
Employees32,000
Revenue 14.7B USD (2024)
DESCRIPTION

Viatris is a generic and specialty pharmaceutical company. Viatris offers the industry's broadest and highest quality product portfolios, a robust product pipeline, and a global commercial footprint through operations in more than 90 countries. Viatris was founded in 1961 and is based in Canonsburg, Pennsylvania.


Deal Context for Buyer #
Overall 7 of 14
Sector: Life Science 5 of 11
Type: Add-on Acquisition 3 of 5
Country: India 3 of 3
Year: 2015 1 of 2
Size (of disclosed) 6 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-12-04 Agila Specialties Pvt.

Bengaluru, India

Agila Specialties Private Limited, a developer, manufacturer and marketer of high-quality generic injectable products.

Buy $1.8B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-02-27 Abbott - Non-U.S. Developed Markets Specialty and Branded Generics

United States

Abbott's Non-U.S. Developed Markets Specialty and Branded Generics Business.

Buy $5.3B

Seller Profile 1

SELLER

AIF Capital

Hong Kong, China

Category Growth Capital Firm
Founded 1994
PE ASSETS 2.0B USD
Size Large
Type Sector Agnostic
DESCRIPTION

AIF Capital Ltd. is an independent private equity firm focused on investment opportunities across Asia, including China, India, and Southeast Asia. AIF looks for businesses benefiting from Asia's rising domestic consumption and the growth of the middle-class. Sectors of interest include supply chain management, financial services, manufacturing, consumer products, engineering services, energy, retail, distribution, healthcare, media, telecom, and transportation. Target transaction situations include growth capital financings, buyouts, and special situations. AIF Capital was formed in 1994 and is based in Hong Kong with additional offices in Beijing, and Singapore.


Deal Context for Seller #
Overall 5 of 6
Sector: Life Science 1 of 1
Type: Add-on Acquisition 2 of 2
Country: India 2 of 2
Year: 2015 2 of 2
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-01-01 Indus Towers

Gurugram, India

Indus Towers is an operator of telecommunication services businesses in India. Bharti's primary assets include national and international long distance licenses, cellular licenses in four metropolitan cities and 11 states and fixed line licenses in five states. Indus Towers was founded in 2006 and is based in Gurugram, Haryana.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-04-02 X-FIPER

Suzhou City, China

X-FIPER is a manufacturer of meta-aramid fiber and its related products in the world with its products sold both domestically and overseas market including Southeast Asia, the U.S., and Europe. X-FIPER is based in Suzhou City, China.

Buy -